Effectiveness, Quality of Life and Durability of Risankizumab in Patients with Moderate-to-Severe Psoriasis: Real-World Evidence from the PRIMMA Study.
Saved in:
| Title: | Effectiveness, Quality of Life and Durability of Risankizumab in Patients with Moderate-to-Severe Psoriasis: Real-World Evidence from the PRIMMA Study. |
|---|---|
| Authors: | Snast, Igor1 (AUTHOR), Valdman-Grinshpoun, Yuliya2,3 (AUTHOR), Bathish, Naji4 (AUTHOR), Matz, Hagit5,6 (AUTHOR), Shclar, Yuri7,8 (AUTHOR), Murad, Sari9,10 (AUTHOR), Czarnowicki, Tali11 (AUTHOR), Shavit, Eran6,12 (AUTHOR) eransh@wmc.gov.il, Yang, Liuqing13 (AUTHOR), Goss, Sandra13 (AUTHOR), Maor, Inbal Piller14 (AUTHOR), Halperin, Assaf14 (AUTHOR), Blonder, Shiran Naftalberg14 (AUTHOR), Cohen, Raanan14 (AUTHOR), Bleterman, Alex14 (AUTHOR), Barak, Moran14 (AUTHOR), Pavlovsky, Lev1,6 (AUTHOR) levp@clalit.org.il |
| Source: | Dermatology & Therapy. May2026, Vol. 16 Issue 5, p2525-2540. 16p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 21938210 |
|---|---|
| DOI: | 10.1007/s13555-026-01729-7 |
